1. Home
  2. RZLT vs JSPR Comparison

RZLT vs JSPR Comparison

Compare RZLT & JSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RZLT
  • JSPR
  • Stock Information
  • Founded
  • RZLT 2010
  • JSPR 2018
  • Country
  • RZLT United States
  • JSPR United States
  • Employees
  • RZLT N/A
  • JSPR N/A
  • Industry
  • RZLT Biotechnology: Pharmaceutical Preparations
  • JSPR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RZLT Health Care
  • JSPR Health Care
  • Exchange
  • RZLT Nasdaq
  • JSPR Nasdaq
  • Market Cap
  • RZLT 292.0M
  • JSPR 325.7M
  • IPO Year
  • RZLT N/A
  • JSPR N/A
  • Fundamental
  • Price
  • RZLT $5.01
  • JSPR $22.50
  • Analyst Decision
  • RZLT Strong Buy
  • JSPR Strong Buy
  • Analyst Count
  • RZLT 8
  • JSPR 11
  • Target Price
  • RZLT $11.63
  • JSPR $73.38
  • AVG Volume (30 Days)
  • RZLT 388.2K
  • JSPR 176.2K
  • Earning Date
  • RZLT 02-11-2025
  • JSPR 11-07-2024
  • Dividend Yield
  • RZLT N/A
  • JSPR N/A
  • EPS Growth
  • RZLT N/A
  • JSPR N/A
  • EPS
  • RZLT N/A
  • JSPR N/A
  • Revenue
  • RZLT N/A
  • JSPR N/A
  • Revenue This Year
  • RZLT N/A
  • JSPR N/A
  • Revenue Next Year
  • RZLT N/A
  • JSPR N/A
  • P/E Ratio
  • RZLT N/A
  • JSPR N/A
  • Revenue Growth
  • RZLT N/A
  • JSPR N/A
  • 52 Week Low
  • RZLT $0.90
  • JSPR $6.20
  • 52 Week High
  • RZLT $6.19
  • JSPR $31.01
  • Technical
  • Relative Strength Index (RSI)
  • RZLT 55.17
  • JSPR 53.62
  • Support Level
  • RZLT $4.07
  • JSPR $20.77
  • Resistance Level
  • RZLT $4.64
  • JSPR $23.11
  • Average True Range (ATR)
  • RZLT 0.36
  • JSPR 1.59
  • MACD
  • RZLT 0.01
  • JSPR -0.01
  • Stochastic Oscillator
  • RZLT 67.14
  • JSPR 68.97

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.

About JSPR Jasper Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Share on Social Networks: